Didi has lived with diabetes for many years, which can be a leading contributor to kidney disease. Still, learning her kidneys were failing was a shock. Fortunately, she had the support of her family and healthcare providers to explore the therapy options that met her clinical and lifestyle needs. Didi decided home peritoneal dialysis (PD) was the right path for her.
Originally from the Philippines, Didi came to the United States to obtain her Master’s degree, during which time she met her husband, traveled extensively and has now lived in Illinois for the past 37 years. Married with three grown children and several grandchildren, Didi and her husband live an active lifestyle.
Didi manages her home therapy on the AMIA automated peritoneal dialysis system with the SHARESOURCE remote patient management platform. SHARESOURCE allows healthcare providers to securely view their patients’ recently completed home dialysis-related treatment data that is automatically collected after each PD session. Healthcare providers can then act on this information by remotely adjusting their patients’ home device settings without requiring them to travel to the clinic.
“My home dialysis system talks me through therapy; it’s like having a friend in the room with you,” said Didi. “My favorite part of the system is its remote connectivity feature, because I know my nurse can see how my treatments are going and call if something doesn’t look right.”
Today, Didi has been able to largely resume the lifestyle she enjoyed before she began dialysis treatment, spending time with family and pursuing her hobbies and other interests.
“The kidneys are a horrible thing to lose, Didi added. “I’m thankful to have the opportunity to live as normally as possible.”
Learn more about peritoneal dialysis with our essential online resource for renal healthcare professionals and patients living with chronic kidney disease (CKD) at pdempowers.com
The following video about SHARESOURCE Connectivity Platform features HomeChoice Claria. HomeChoice Claria is currently not marketed in Canada.